Social Media Ideas for Insm

Latest updates for Insm

Fresh curated links around INSM are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fool.com /3 weeks ago

Insmed (INSM) Q2 2026 Earnings Call Transcript

BRINSUPRI revenue surged to $309.2 million, driving total revenues to $425.5 million.

Read source

fool.com /1 month ago

What This Immunome Sale Means a Day Before a Big FDA Milestone

Barchas maintains 211,763 residual shares through direct and indirect holdings following execution under a Rule 10b5-1 trading plan adopted in March 2026.

Read source

seekingalpha.com /4 weeks ago

Insight Molecular Diagnostics Q2 2026 Earnings Preview

Read source

seekingalpha.com /1 month ago

Tracking Baker Brothers Portfolio: Q1 2026 Update

Read source

fool.com /1 month ago

INmune Bio (INMB) Q2 2026 Earnings Call Transcript

Ebstracel nears UK filing as XPro shows Alzheimer's biomarker progress.

Read source

finance.yahoo.com /5 days ago

Unique Payer Network Strengthens InfuSystem (INFU)

Read source

seekingalpha.com /1 month ago

Inhibrx Biosciences: The Whole Story Rides On INBRX-106

Read source

pharmexec.com /1 month ago

<![CDATA[Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals ]]>

Read source

seekingalpha.com /1 month ago

ImmunityBio: ANKTIVA's Commercial Momentum Supports A Buy

Read source

seekingalpha.com /2 weeks ago

TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors

Read source

seekingalpha.com /1 month ago

ImmunityBio: Intriguing Progress, If Not (Yet) Commercially - Still A Hold

Read source

newswire.com /1 month ago

Ensysce Biosciences Announces Acquisition of Cy Biopharma and up to $77 Million Private Financing

Acquisition includes clinical-stage neuroplastogenic therapy with U.S. FDA Orphan Drug Designation for the treatment of Complex Regional Pain Syndrome (CRPS)Up to $77 million in pr...

Read source

forbes.com /1 month ago

The Startup Behind The Pill For Sleep Apnea Raises $192 Million In IPO

Apnimed got a new CEO in anticipation of its public offering. Its pill for sleep apnea could receive approval early next year.

Read source

seekingalpha.com /1 week ago

Immuron reports FY results

Read source

iknowfirst.com /1 month ago

Medicine Stocks Based on Artificial Intelligence: Returns up to 31.4% in 14 Days

Package Name: Medicine Stocks Recommended Positions: Long Forecast Length: 14 Days (7/16/26 - 7/30/26) I Know First Average: 8.61% Read The Full Forecast...

Read source

seekingalpha.com /1 month ago

AtaiBeckley: 'Hold'; Eli Lilly Acquisition For $2.8 Billion Adds To Its Neuroscience Pipeline

Read source

newswire.com /1 month ago

Aimwell Partners Inc. (OTC: AIMN) Enters Final Negotiations to Acquire Healthcare Intellectual Property Independently Va...

Read source

finance.yahoo.com /4 weeks ago

Incyte Sales Growth Drives Share Price Gains

Read source

cafepharma.com /1 week ago

How is Insmed to work?

How is Insmed to work? Anonymous (not verified) Thu, 08/27/2026 - 09:40 field_thread_url https://cafepharma.com/boards/threads/how-is-insmed-to-work.690823...

Read source

seekingalpha.com /1 week ago

InfuSystems: More Upside Ahead

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.